Fig. 4From: PRICKLE1, a Wnt/PCP signaling component, is overexpressed and associated with inferior prognosis in acute myeloid leukemiaAssociation of PRICKLE1 expression with European LeukemiaNet (ELN) risk classification in AML patients. PRICKLE1 expression difference between patients with good-risk cytogenetic classification and intermediate/poor-risk cytogenetic classification (a), and patients with gene mutations [FLT3 (b), CEBPA (c), DNMT3A (d), IDH2 (e) and IDH1 (f)]Back to article page